NK-Cell Therapy – VJRegenMed https://mirror.vjregenmed.com The Video Journal of Regenerative Medicine Wed, 25 Aug 2021 11:22:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://d2xz56kaqxj8if.cloudfront.net/wp-content/uploads/2023/09/12102509/VJR-Favicon.png NK-Cell Therapy – VJRegenMed https://mirror.vjregenmed.com 32 32 NK-CAR immunotherapy: where are we now? https://mirror.vjregenmed.com/video/ursnkl2riek-nk-car-immunotherapy-where-are-we-now/ Fri, 26 Feb 2021 14:08:27 +0000 http://13.40.107.223/video/ursnkl2riek-nk-car-immunotherapy-where-are-we-now/ Natural killer (NK) cells are an essential component of the innate immune system and can provide a valuable source of allogeneic adoptive therapy. Concetta Quintarelli, PhD, Bambino Gesù Children Hospital, IRCCS, Rome, Italy, discusses the generation of allogeneic CAR products, in particular CAR NK-cells. Prof. Quintarelli reveals that using bioreactors, her group has generated up to 300 doses of CAR NK-cells. Although the transition from autologous to allogeneic products is challenging, especially the manufacturing process, the group is now generating the NK-cell banks for both hematological malignancies and solid tumors. This interview took place during the 3rd European CAR T-cell Meeting.

]]>